Birmingham is becoming a leading location for Life...
In an exclusive interview with Biotech and Money, Chris Yates,a prominent t...
Read MoreThe headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.
Remember:
Get our executive insight into your inbox
In an exclusive interview with Biotech and Money, Chris Yates,a prominent t...
Read MoreAnker Lundemose, CEO of MISSION Therapeutics talks to Biotech and Money abo...
Read MoreBiotech and Money had the opportunity to speak to Neil Campbell of Helomics...
Read MoreWe recently spoke to Eddy Littler of Domainex about discovering new therapi...
Read MoreDr John Beadle, CEO of PsiOxus Therapeutics outlines what the investment wi...
Read MoreNewly appointed Chairman and CEO, Chris Yates discusses the potential of Ab...
Read MoreThe Drugs & Dealers Blog provides genuine thought leadership, exclusive executive insight and market intelligence on the life science and healthcare investment sector.
Connecting Europe's Life Science corporates with capital.
Biotech and Money is the influential community of senior life science decision makers
© 2016 All Rights Reserved By Biotech and Money
Add Your Response